journal article·2024-10-25Open access

Sodium Alginate Microneedles Loaded with Vancomycin for Skin Infections

Juhaina M. Abu Ershaid, Han Zhang, May Tayyem, Akmal H. Sabri, Ryan F. Donnelly, Lalitkumar K. Vora

Journal of Functional Biomaterials· Volume 15· Issue 11

Abstract

Background: Skin and soft tissue infections (SSTIs) present significant treatment challenges. These infections often require systemic antibiotics such as vancomycin, which poses a risk for increased bacterial resistance. Topical treatments are hindered by the barrier function of the skin, and microneedles (MNs) offer a promising solution, increasing patient compliance and negating the need for traditional needles. Methods: This study focused on the use of sodium alginate MNs for vancomycin delivery directly to the site of infection via a cost-effective micromolding technique. Dissolving polymeric MNs made of sodium alginate and loaded with vancomycin were fabricated and evaluated in terms of their physical properties, delivery ability, and antimicrobial activity. Results: The MNs achieved a 378 μm depth of insertion into ex vivo skin and a 5.0 ± 0 mm zone of inhibition in agar disc diffusion assays. Furthermore, in ex vivo Franz cell experiments, the MNs delivered 34.46 ± 11.31 μg of vancomycin with around 35% efficiency, with 9.88 ± 0.57 μg deposited in the skin after 24 h. Conclusions: These findings suggest that sodium alginate MNs are a viable platform for antimicrobial agent delivery in SSTIs. Future in vivo studies are essential to confirm the safety and effectiveness of this innovative method for clinical use.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Wound Healing and Treatments · Bacterial biofilms and quorum sensing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK

School of Pharmacy, Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Isra University, Amman 11622, Jordan

School of Pharmacy, Department of Pharmaceutical Technology and Cosmetics, Middle East University, Airport Road, Amman 11831, Jordan

School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK

References (48)

Show source-provided references
1. Nandhini, P., Kumar, P., Mickymaray, S., Alothaim, A.S., Somasundaram, J., and Rajan, M. (2022). Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review. Antibiotics, 11.10.3390/antibiotics11050606 ↗
2. Emerging strategies to combat methicillin-resistant Staphylococcus aureus (MRSA): Natural agents with high potential10.2174/1381612829666230410095155 ↗
3. Staphylococcus aureus from the German general population is highly diverse10.1016/j.ijmm.2016.11.007 ↗
4. Identifying infection in chronic wounds in a community setting: A systematic review of diagnostic test accuracy studies10.1111/jan.15822 ↗
5. Beshiru, A., Isichei-Ukah, B.O., Uwhuba, K.E., Igere, B.E., and Igbinosa, E.O. (2024). Prevalence, characterization, and implications of methicillin-resistant Staphylococcus aureus (MRSA) in ready-to-eat foods from Delta, Nigeria: A concern for consumer safety. Sustain. Microbiol., 1.10.1093/sumbio/qvae007 ↗
6. Preventing drug-resistant infections in health care
7. Staphylococcus aureus: Overview of bacteriology, clinical diseases, epidemiology, antibiotic resistance and therapeutic approach
8. A model for surveillance of methicillin-resistant Staphylococcus aureus10.1177/003335490812300104 ↗
9. Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia10.3947/ic.2016.48.4.267 ↗
10. Methicillin-Resistant Staphylococcus aureus (MRSA): One Health Perspective Approach to the Bacterium Epidemiology, Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact10.2147/IDR.S272733 ↗
11. Efficacy and safety of vancomycin loading doses in critically ill patients with methicillin-resistant Staphylococcus aureus infection
12. Methicillin-resistant Staphylococcus aureus: An overview for manual therapists10.1016/j.jcm.2011.12.001 ↗
13. The structural biology of molecular recognition by vancomycin10.1146/annurev.biophys.29.1.265 ↗
14. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers10.1016/j.ijpharm.2021.120663 ↗
15. Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection10.1093/ofid/ofad258 ↗
16. Abu Ershaid, J.M., Vora, L.K., Volpe-Zanutto, F., Sabri, A.H., Peng, K., Anjani, Q.K., McKenna, P.E., Ripolin, A., Larrañeta, E., and McCarthy, H.O. (2023). Microneedle array patches for sustained delivery of fluphenazine: A micron scale approach for the management of schizophrenia. Biomater. Adv., 153.10.1016/j.bioadv.2023.213526 ↗
17. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery10.1007/s13346-021-01107-0 ↗
18. Therapeutic monitoring of vancomycin in adults: Summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists10.1592/phco.29.11.1275 ↗
19. Biodegradable microneedle fabricated from sodium alginate-gelatin for transdermal delivery of clindamycin10.1016/j.mtcomm.2022.104158 ↗
20. Demir, Y.K., Akan, Z., and Kerimoglu, O. (2013). Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin. PLoS ONE, 8.10.1371/journal.pone.0063819 ↗
21. Dual cross-linking mechanism of sodium alginate composite hydrogel for adhesive microneedle patch preparation10.1016/j.colsurfa.2024.134777 ↗
22. Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride10.1016/j.jconrel.2023.02.031 ↗
23. Engineering and characterisation of BCG-loaded polymeric microneedles10.1080/1061186X.2019.1693577 ↗
24. A proposed model membrane and test method for microneedle insertion studies10.1016/j.ijpharm.2014.05.042 ↗
25. Ganeson, K., Alias, A.H., Murugaiyah, V., Amirul, A.-A.A., Ramakrishna, S., and Vigneswari, S. (2023). Microneedles for efficient and precise drug delivery in cancer therapy. Pharmaceutics, 15.10.3390/pharmaceutics15030744 ↗
26. Ramadon, D., Courtenay, A.J., Permana, A.D., Tekko, I.A., McAlister, E., McCrudden, M.T., McCarthy, H.O., and Donnelly, R.F. (2020). A sensitive HPLC-UV method for quantifying vancomycin in biological matrices: Application to pharmacokinetic and biodistribution studies in rat plasma, skin and lymph nodes. J. Pharm. Biomed. Anal., 189.10.1016/j.jpba.2020.113429 ↗
27. Two-photon polymerisation 3D printing of microneedle array templates with versatile designs: Application in the development of polymeric drug delivery systems10.1007/s11095-020-02887-9 ↗
28. Clinical and Laboratory Standards Institute (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents, Clinical and Laboratory Standards Institute. Approved Guideline.
29. Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections10.1016/j.jconrel.2021.10.001 ↗
30. Wiederhold, N.P. (2023). Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing. Antifungal Drug Resistance: Methods and Protocols, Springer.10.1007/978-1-0716-3155-3_1 ↗
31. Highly prolonged release of the cancer vaccine and immunomodulator via a two-layer biodegradable microneedle for prophylactic treatment of metastatic cancer10.1021/acs.biomac.2c01270 ↗
32. Microarray patches: Poking a hole in the challenges faced when delivering poorly soluble drugs10.1002/adfm.202005792 ↗
33. Dawud, H., and Abu Ammar, A. (2023). Rapidly dissolving microneedles for the delivery of steroid-loaded nanoparticles intended for the treatment of inflammatory skin diseases. Pharmaceutics, 15.10.3390/pharmaceutics15020526 ↗
34. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept10.1016/j.jconrel.2017.10.005 ↗
35. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications10.1016/j.mattod.2022.12.007 ↗
36. Interactions between gelatin and sodium alginate: UV and FTIR studies10.1080/01932691.2019.1611437 ↗
37. Characterization of sodium alginate based films
38. Characterization of poly (vinyl alcohol)/poly (ethylene glycol) hydrogels and PVA-derived hybrids by small-angle X-ray scattering and FTIR spectroscopy10.1016/j.polymer.2004.08.036 ↗
39. Determination of the degree of crystallinity of poly (vinyl alcohol) by FTIR spectroscopy10.1007/s10812-012-9634-y ↗
40. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity10.1016/j.colsurfb.2018.12.043 ↗
41. Synthesis and characterization of vancomycin-loaded chitosan nanoparticles for drug delivery10.1007/s00289-022-04237-8 ↗
42. Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii10.1016/j.jconrel.2021.03.036 ↗
43. Development, evaluation, and pharmacokinetic assessment of polymeric microarray patches for transdermal delivery of vancomycin hydrochloride10.1021/acs.molpharmaceut.0c00431 ↗
44. Vancomycin-Loaded Microneedle Arrays against Methicillin-Resistant Staphylococcus Aureus Skin Infections10.1002/admt.202001307 ↗
45. Deepa, B., Abraham, E., Pothan, L.A., Cordeiro, N., Faria, M., and Thomas, S. (2016). Biodegradable nanocomposite films based on sodium alginate and cellulose nanofibrils. Materials, 9.10.3390/ma9010050 ↗
46. Foster, T.J. (2020). Surface proteins of Staphylococcus epidermidis. Front. Microbiol., 11.10.3389/fmicb.2020.01829 ↗
47. Mechanisms of vancomycin resistance in Staphylococcus aureus10.1172/JCI68834 ↗
48. Fabrication and characterisation of poly (sulfonated) and poly (sulfonic acid) dissolving microneedles for delivery of antibiotic and antifungal agents10.1016/j.ijpharm.2023.123292 ↗